During Patient Safety Awareness Week 2026, OctariusRx highlights pharmacist-led strategies—audits, training, and interdisciplinary collaboration—that help ambulatory surgery centers reduce medication risk and improve patient outcomes.
Tag: Patient safety
Post
Malignant Hyperthermia (MH) Awareness & Training Month — March
March is Malignant Hyperthermia Awareness & Training Month—a vital reminder for ASCs to review protocols, train staff, and ensure readiness to manage MH emergencies effectively.
Post
The 2026 Controlled Substances Assessment Quiz
The 2026 Controlled Substances Assessment Quiz from OctariusRx — updated for current DEA guidance. Use this annual competency tool to assess staff, reduce diversion risk, and document compliance for ASCs and healthcare facilities.
Post
What’s New in the 2025 MHAUS OR Poster for ASCs — What Ambulatory Surgery Centers Need to Know
An overview of the 2025 MHAUS OR poster updates and what they mean for ASC malignant hyperthermia preparedness, compliance, and patient safety.
Post
Drug Shortages Update: January 2026
This week we are once again providing an update on the most recent drug shortages noting 75 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
Post
Navigating the Trypan Blue Shortage: Practical Guidance for Ophthalmology ASCs
Learn how ophthalmology ASCs can safely navigate the trypan blue shortage using pharmacist-led strategies, clinical alternatives, and conservation best practices.
Post
The Year in Review: 2025
Another year has flown by. Unbelievably, we are quickly approaching 2026 and it’s time to look back at the biggest topics of 2025.
Post
Happy Thanksgiving!
This Thanksgiving, OctariusRx celebrates gratitude for our clients, partners, and healthcare teams. Wishing you a joyful and peaceful holiday!
Post
The 2025 USP 800 Assessment Quiz: Preparing Your Facility for Compliance and Safety
The 2025 USP 800 Assessment Quiz from OctariusRx helps facilities meet regulatory requirements, strengthen staff competency, and promote patient and staff safety.
Post
2025 FDA Updates on Tranexamic Acid: What Ambulatory Surgery Centers Need to Know
The FDA’s 2025 update on tranexamic acid strengthens safety warnings for IV-only use and mandates new labeling. Learn how OctariusRx helps ASCs stay compliant and enhance medication safety.